Aspira Women's Health Inc.
AWHL· OTC
Released Nov 8, 2017, after the close
10-Q filed Nov 8, 2017, 39 days after period end · 0000926617-17-000068
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $699.00K | $623.00K | $330.00K | $323.00K |
| Net Income | -$2.51M | -$3.48M | -$5.15M | -$5.59M |
| EPS Diluted |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.06 |
| -$0.07 |
| -$0.10 |
| -$0.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.